Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

Trial Profile

Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 12 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 05 Feb 2015 Planned primary completion date changed from 1 Oct 2013 to 1 Dec 2015, as reported by ClinicalTrials.gov.
    • 05 Feb 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top